Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Henry; James Robert
Address:
Indianapolis, IN
No. of patents:
10
Patents:












Patent Number Title Of Patent Date Issued
8114872 Triazolyl aminopyrimidine compounds February 14, 2012
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.
8101628 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer January 24, 2012
The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. wherein: R.sup.1 hydrogen, hydroxy, halo, methyl, C.sub.1-C.sub.2 alkoxy, amino, or methylamino; R.sup.2 is hydrogen, halo, o
8063212 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer November 22, 2011
The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. Formula I wherein: R.sup.1 is aminomethyl, (C.sub.1-C.sub.3 alkyl)aminomethyl, di(C.sub.1-C.sub.2 alkyl)aminomethyl, N-ethyl-
8063035 Triazolyl aminopyrimidine compounds November 22, 2011
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.
8058425 Purine derivatives as kinase inhibitors November 15, 2011
The present invention provides kinase inhibitors of Formula I. ##STR00001##
8022065 Purine derivatives as kinase inhibitors September 20, 2011
The present invention provides kinase inhibitors of Formula I. ##STR00001##
7666879 Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors February 23, 2010
The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds. ##STR00001##
7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors July 29, 2008
The present invention provides kinase inhibitors of Formula (I) ##STR00001##
7282501 Modulators of peroxisome proliferator activated receptors (PPAR) October 16, 2007
The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arterioscle
6984661 Urea linker derivatives for use as PPAR modulators January 10, 2006
The present invention is directed to compounds of the structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof: Formula I (a) R1, R2 and R6 are each independently selected from the group consisting of hydrogen, C.sub.1-C.sub.8 alkyl substituted C.s










 
 
  Recently Added Patents
Control service for relational data management
Substituted bicyclic HCV inhibitors
Process for preparing higher hydridosilanes
Prioritizing application data for transmission in a wireless user device
Mobile communication terminal provided with handsfree function and controlling method thereof
Wireless communication method, wireless communication system, and mode switching method
Mobile terminal apparatus, radio base station apparatus and radio communication method
  Randomly Featured Patents
Portable heater
Methods and arrangements in a mobile telecommunications network
Tangential drive needle bar shifter for tufting machines
Inkjet printer cartridge with even distribution of compressed air
Sound attenuating laminate materials
Mounting equipment used for an object having a hollow portion of circular cross section
Autonomic installation and configuration of an enterprise business process on-demand
Multilayer magnetooptic recording media
Solenoid actuator
Process for producing silicon single crystal